(Q51743402)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19333790%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

title

Evaluation of CD44 and CD44v6 in colorectal carcinoma patients: soluble forms in relation to tumor tissue expression and metastasis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19333790%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19333790%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Seyed Vahid Hosseini

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19333790%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

author name string

Zahra Amirghofran

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19333790%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Mohammad Vasei

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19333790%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Behnam Sabayan

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19333790%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Abbas Ghaderi

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19333790%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

publication date

1 January 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19333790%20AND%20SRC:MED&resulttype=core&format=json

Journal of gastrointestinal cancer

25 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19333790%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

volume

39

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19333790%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

issue

1-4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19333790%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

page(s)

73-78

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19333790%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s12029-009-9062-2

25 January 2020

exact match

0 references

cites work

Levels of v5 and v6 CD44 splice variants in serum of patients with colorectal cancer are not correlated with pT stage, histopathological grade of malignancy and clinical features

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS12029-009-9062-2

Expression of proliferating cell nuclear antigen and CD44 variant exon 6 in primary tumors and corresponding lymph node metastases of colorectal carcinoma with Dukes' stage C or D.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS12029-009-9062-2

Serum CD44 splice variants in cervical cancer patients

21 January 2018

1 reference

12 December 2020

Epidemiological changes in colorectal cancer in Shiraz, Iran: 1980-2000.

1 reference

12 December 2020

New CD44 splice variants associated with human breast cancers

1 reference

12 December 2020

Soluble CD44 and CD44v6 serum levels in patients with colorectal cancer are independent of tumor stage and tissue expression of CD44v6.

1 reference

12 December 2020

Lymphocyte adhesion to endothelium

1 reference

12 December 2020

Soluble CD44 Variants in the Serum of Patients with Urological Malignancies

1 reference

12 December 2020

Predictive factors of years of potential life lost by colorectal cancer

1 reference

12 December 2020

Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons

1 reference

12 December 2020

Comparison of CD44 expression in primary tumours and metastases of colorectal cancer

1 reference

12 December 2020

Soluble CD44v6 is not a sensitive tumor marker in patients with head and neck squamous cell cancer

1 reference

12 December 2020

Monoclonal antibodies against the CD44 [In(Lu)-related p80], and Pgp-1 antigens in man recognize the Hermes class of lymphocyte homing receptors

1 reference

12 December 2020

Low serum levels of soluble CD44 variant 6 are significantly associated with poor prognosis in patients with pancreatic carcinoma

1 reference

12 December 2020

Monoclonal antibody to a human leukocyte-specific membrane glycoprotein probably homologous to the leukocyte-common (L-C) antigen of the rat

1 reference

12 December 2020

A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells

1 reference

12 December 2020

Shedding of the CD44 adhesion molecule from leukocytes induced by anti-CD44 monoclonal antibody simulating the effect of a natural receptor ligand

1 reference

12 December 2020

Does soluble CD44 reflect the clinical behavior of human cancer?

1 reference

12 December 2020

Soluble CD44 secretion contributes to the acquisition of aggressive tumor phenotype in human colon cancer cells

1 reference

12 December 2020

Long-term outcome after combined radiochemotherapy for anal cancer - retrospective analysis of efficacy, prognostic factors, and toxicity

1 reference

12 December 2020

Expression of CD44 splice variants in human cutaneous melanoma and melanoma cell lines is related to tumor progression and metastatic potential

1 reference

12 December 2020

Tumor cell interactions with the microvasculature: a rate-limiting step in metastasis

1 reference

12 December 2020

Soluble CD44 variant 6 as a prognostic indicator in patients with colorectal cancer

1 reference

12 December 2020

Soluble CD44: quantification and molecular repartition in plasma of patients with colorectal cancer

1 reference

12 December 2020

Tumor-endothelial cell interactions: therapeutic potential

1 reference

12 December 2020

The liberation of CD44.

1 reference

12 December 2020

Soluble CD44 molecules in serum of patients with prostate cancer and benign prostatic hyperplasia

1 reference

12 December 2020